Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
27
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Smith Julie Diana | Sr VP, Controller, PAO | 8 | $0 | $0 | 2023-01-31 |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | 16 | $0 | $0 | 2023-01-31 |
| Kitzmiller Andrew S. | Executive Vice President & CFO | 6 | $100.2K | $0 | 2023-01-31 |
| Kenny John P. | Chief Executive Officer | 56 | $634.3K | $9.14M | 2023-01-31 |
| Rice John McCune Jr. | Director | 27 | $59.8K | $464.1K | 2023-01-31 |
| Williams Felicia | Director | 16 | $9.3K | $0 | 2023-01-31 |
| Sazdanoff Catherine | Director | 22 | $147.8K | $0 | 2023-01-31 |
| McIlwraith John | Director | 28 | $123.0K | $0 | 2023-01-31 |
| Ellingwood Dwight E | Director | 48 | $78.0K | $0 | 2023-01-31 |
| Anderson James M. | Director | 31 | $56.8K | $0 | 2023-01-31 |
| Bihl Anthony P III | Director | 13 | $178.2K | $0 | 2023-01-31 |
| WELTZIEN LOURDES | Executive VP, Life Science | 30 | $0 | $512.0K | 2023-01-31 |
| PHILLIPS DAVID | Director | 42 | $306.5K | $0 | 2022-01-12 |
| Baldasare Bryan T | Interim CFO & Chief Acctg Off | 23 | $13.9K | $566.8K | 2021-12-15 |
| BALDINI LAWRENCE | Exec VP, Operations & IS | 46 | $781.5K | $2.22M | 2018-12-15 |
| LUEKE MELISSA | Exec VP, CFO | 42 | $50.4K | $525.4K | 2018-12-15 |
| ROLIH SUSAN | Sr. VP, Reg Affairs and QA | 41 | $0 | $404.4K | 2018-11-16 |
| Rasmussen Eric S. | EVP, Bus. Development/Strategy | 3 | $0 | $0 | 2018-11-15 |
| Winslow Amy | EVP, Pres & CEO of Magellan | 9 | $0 | $0 | 2017-11-09 |
| Calzavara Marco G. | Pres & Managing Director, MBE | 21 | $0 | $69.8K | 2017-11-09 |
| Elagin Vecheslav A | EVP, Research & Development | 29 | $0 | $382.8K | 2017-11-09 |
| KRAEUTLER JOHN A | Executive Chairman | 43 | $274.5K | $302.8K | 2017-11-09 |
| EBERLY RICHARD | EVP; Pres, Chief Comm Officer | 36 | $0 | $1.02M | 2017-11-09 |
| Shaughnessy Michael C. | EVP, Pres Meridian Global Dx | 7 | $0 | $0 | 2016-03-24 |
| Johnson Marviette D. | VP, Human Resources | 12 | $0 | $38.2K | 2015-03-02 |
| READY ROBERT J | Director | 17 | $0 | $441.0K | 2015-01-22 |
| MOTTO WILLIAM J | Executive Chairman | 35 | $0 | $648.0K | 2014-05-15 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Smith Julie Diana | Sr VP, Controller, PAO | D To issuer deriv | 2023-01-31 | 2023-01-31 | 2,000 | $27.03 | $54.1K | 0 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | D To issuer deriv | 2023-01-31 | 2023-01-31 | 12,107 | $15.52 | $187.9K | 0 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | D To issuer deriv | 2023-01-31 | 2023-01-31 | 10,000 | $19.40 | $194.0K | 0 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | D To issuer deriv | 2023-01-31 | 2023-01-31 | 4,000 | $27.03 | $108.1K | 0 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | D To issuer deriv | 2023-01-31 | 2023-01-31 | 11,669 | $15.12 | $176.4K | 0 | SEC↗ |
| WELTZIEN LOURDES | Executive VP, Life Science | D To issuer deriv | 2023-01-31 | 2023-01-31 | 10,000 | $14.34 | $143.4K | 0 | SEC↗ |
| WELTZIEN LOURDES | Executive VP, Life Science | D To issuer deriv | 2023-01-31 | 2023-01-31 | 2,500 | $19.70 | $49.3K | 0 | SEC↗ |
| WELTZIEN LOURDES | Executive VP, Life Science | D To issuer deriv | 2023-01-31 | 2023-01-31 | 12,107 | $15.52 | $187.9K | 0 | SEC↗ |
| WELTZIEN LOURDES | Executive VP, Life Science | D To issuer deriv | 2023-01-31 | 2023-01-31 | 11,669 | $15.12 | $176.4K | 0 | SEC↗ |
| Kitzmiller Andrew S. | Executive Vice President & C | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,000 | $9.26 | $46.3K | 0 | SEC↗ |
| Kenny John P. | Chief Executive Officer | D To issuer deriv | 2023-01-31 | 2023-01-31 | 66,039 | $23.90 | $1.58M | 0 | SEC↗ |
| Kenny John P. | Chief Executive Officer | D To issuer deriv | 2023-01-31 | 2023-01-31 | 83,535 | $15.52 | $1.30M | 0 | SEC↗ |
| Kenny John P. | Chief Executive Officer | D To issuer deriv | 2023-01-31 | 2023-01-31 | 82,940 | $15.12 | $1.25M | 0 | SEC↗ |
| Anderson James M. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,500 | $15.36 | $130.6K | 0 | SEC↗ |
| Anderson James M. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,740 | $17.03 | $148.8K | 0 | SEC↗ |
| Anderson James M. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 12,000 | $17.80 | $213.6K | 0 | SEC↗ |
| Anderson James M. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,656 | $13.25 | $74.9K | 0 | SEC↗ |
| Anderson James M. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,796 | $12.64 | $73.3K | 0 | SEC↗ |
| Anderson James M. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 12,000 | $21.20 | $254.4K | 0 | SEC↗ |
| Anderson James M. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 17,205 | $23.54 | $405.0K | 0 | SEC↗ |
| Anderson James M. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,500 | $16.66 | $141.6K | 0 | SEC↗ |
| Anderson James M. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,500 | $8.17 | $69.4K | 0 | SEC↗ |
| Bihl Anthony P III | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,796 | $12.64 | $73.3K | 0 | SEC↗ |
| Bihl Anthony P III | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 4,595 | $10.50 | $48.2K | 0 | SEC↗ |
| Bihl Anthony P III | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,656 | $13.25 | $74.9K | 0 | SEC↗ |
| Ellingwood Dwight E | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 12,000 | $17.80 | $213.6K | 0 | SEC↗ |
| Ellingwood Dwight E | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,500 | $16.66 | $91.6K | 0 | SEC↗ |
| Ellingwood Dwight E | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 17,205 | $23.54 | $405.0K | 0 | SEC↗ |
| Ellingwood Dwight E | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,740 | $17.03 | $148.8K | 0 | SEC↗ |
| Ellingwood Dwight E | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,796 | $12.64 | $73.3K | 0 | SEC↗ |
| Ellingwood Dwight E | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 11,000 | $21.20 | $233.2K | 0 | SEC↗ |
| Ellingwood Dwight E | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,500 | $15.36 | $130.6K | 0 | SEC↗ |
| Ellingwood Dwight E | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,656 | $13.25 | $74.9K | 0 | SEC↗ |
| Ellingwood Dwight E | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,500 | $13.20 | $112.2K | 0 | SEC↗ |
| McIlwraith John | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,500 | $15.82 | $134.5K | 0 | SEC↗ |
| McIlwraith John | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,656 | $13.25 | $74.9K | 0 | SEC↗ |
| McIlwraith John | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,796 | $12.64 | $73.3K | 0 | SEC↗ |
| McIlwraith John | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 17,205 | $23.54 | $405.0K | 0 | SEC↗ |
| McIlwraith John | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 12,000 | $17.80 | $213.6K | 0 | SEC↗ |
| McIlwraith John | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,740 | $17.03 | $148.8K | 0 | SEC↗ |
| McIlwraith John | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 10,000 | $21.20 | $212.0K | 0 | SEC↗ |
| McIlwraith John | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,500 | $15.36 | $130.6K | 0 | SEC↗ |
| Rice John McCune Jr. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,740 | $17.03 | $148.8K | 0 | SEC↗ |
| Rice John McCune Jr. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 12,000 | $17.80 | $213.6K | 0 | SEC↗ |
| Rice John McCune Jr. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,796 | $12.64 | $73.3K | 0 | SEC↗ |
| Rice John McCune Jr. | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,656 | $13.25 | $74.9K | 0 | SEC↗ |
| Sazdanoff Catherine | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 12,000 | $17.80 | $213.6K | 0 | SEC↗ |
| Sazdanoff Catherine | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,740 | $17.03 | $148.8K | 0 | SEC↗ |
| Sazdanoff Catherine | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,796 | $12.64 | $73.3K | 0 | SEC↗ |
| Sazdanoff Catherine | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,656 | $13.25 | $74.9K | 0 | SEC↗ |
| Sazdanoff Catherine | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,500 | $15.82 | $134.5K | 0 | SEC↗ |
| Sazdanoff Catherine | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,500 | $15.36 | $130.6K | 0 | SEC↗ |
| Sazdanoff Catherine | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 12,000 | $21.20 | $254.4K | 0 | SEC↗ |
| Sazdanoff Catherine | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 17,205 | $23.54 | $405.0K | 0 | SEC↗ |
| Williams Felicia | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 8,740 | $17.03 | $148.8K | 0 | SEC↗ |
| Williams Felicia | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 12,000 | $18.85 | $226.2K | 0 | SEC↗ |
| Williams Felicia | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,656 | $13.25 | $74.9K | 0 | SEC↗ |
| Williams Felicia | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 5,796 | $12.64 | $73.3K | 0 | SEC↗ |
| Williams Felicia | Director | D To issuer deriv | 2023-01-31 | 2023-01-31 | 17,205 | $23.54 | $405.0K | 0 | SEC↗ |
| Smith Julie Diana | Sr VP, Controller, PAO | D To issuer | 2023-01-31 | 2023-01-31 | 25,600 | — | $0 | 0 | SEC↗ |
| Smith Julie Diana | Sr VP, Controller, PAO | D To issuer | 2023-01-31 | 2023-01-31 | 32,708 | — | $0 | 0 | SEC↗ |
| Smith Julie Diana | Sr VP, Controller, PAO | A Award | 2023-01-31 | 2023-01-31 | 2,648 | — | $0 | 32,708 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | D To issuer | 2023-01-31 | 2023-01-31 | 43,338 | — | $0 | 0 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | A Award | 2023-01-31 | 2023-01-31 | 7,945 | — | $0 | 43,338 | SEC↗ |
| WELTZIEN LOURDES | Executive VP, Life Science | A Award | 2023-01-31 | 2023-01-31 | 7,945 | — | $0 | 86,045 | SEC↗ |
| WELTZIEN LOURDES | Executive VP, Life Science | D To issuer | 2023-01-31 | 2023-01-31 | 86,045 | — | $0 | 0 | SEC↗ |
| Kitzmiller Andrew S. | Executive Vice President & C | D To issuer | 2023-01-31 | 2023-01-31 | 19,473 | — | $0 | 0 | SEC↗ |
| Kitzmiller Andrew S. | Executive Vice President & C | A Award | 2023-01-31 | 2023-01-31 | 7,945 | — | $0 | 19,473 | SEC↗ |
| Kenny John P. | Chief Executive Officer | D To issuer | 2023-01-31 | 2023-01-31 | 267,651 | — | $0 | 0 | SEC↗ |
| Kenny John P. | Chief Executive Officer | A Award | 2023-01-31 | 2023-01-31 | 47,060 | — | $0 | 267,651 | SEC↗ |
| Anderson James M. | Director | D To issuer | 2023-01-31 | 2023-01-31 | 5,000 | — | $0 | 0 | SEC↗ |
| Anderson James M. | Director | D To issuer | 2023-01-31 | 2023-01-31 | 28,224 | — | $0 | 0 | SEC↗ |
| Bihl Anthony P III | Director | D To issuer | 2023-01-31 | 2023-01-31 | 15,408 | — | $0 | 0 | SEC↗ |
| Ellingwood Dwight E | Director | D To issuer | 2023-01-31 | 2023-01-31 | 17,290 | — | $0 | 0 | SEC↗ |
| McIlwraith John | Director | D To issuer | 2023-01-31 | 2023-01-31 | 21,724 | — | $0 | 0 | SEC↗ |
| Rice John McCune Jr. | Director | D To issuer | 2023-01-31 | 2023-01-31 | 27,449 | — | $0 | 0 | SEC↗ |
| Sazdanoff Catherine | Director | D To issuer | 2023-01-31 | 2023-01-31 | 16,424 | — | $0 | 0 | SEC↗ |
| Williams Felicia | Director | D To issuer | 2023-01-31 | 2023-01-31 | 10,274 | — | $0 | 0 | SEC↗ |
| Anderson James M. | Director | M Exercise deriv | 2023-01-06 | 2023-01-09 | 8,500 | — | $0 | 0 | SEC↗ |
| Anderson James M. | Director | M Exercise | 2023-01-06 | 2023-01-09 | 8,500 | $20.38 | $173.2K | 28,224 | SEC↗ |
| Smith Julie Diana | Sr VP, Controller, PAO | F Tax w/h | 2022-12-06 | 2022-12-07 | 374 | $31.71 | $11.9K | 30,060 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | F Tax w/h | 2022-11-15 | 2022-11-17 | 4,382 | $31.83 | $139.5K | 78,100 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | F Tax w/h | 2022-11-15 | 2022-11-17 | 3,666 | $31.83 | $116.7K | 35,393 | SEC↗ |
| Smith Julie Diana | Sr VP, Controller, PAO | F Tax w/h | 2022-11-15 | 2022-11-17 | 1,845 | $31.83 | $58.7K | 30,434 | SEC↗ |
| Kenny John P. | Chief Executive Officer | F Tax w/h | 2022-11-04 | 2022-11-08 | 4,271 | $32.01 | $136.7K | 220,591 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | F Tax w/h | 2022-11-04 | 2022-11-08 | 788 | $32.01 | $25.2K | 39,059 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | F Tax w/h | 2022-11-04 | 2022-11-08 | 566 | $32.01 | $18.1K | 82,482 | SEC↗ |
| Smith Julie Diana | Sr VP, Controller, PAO | F Tax w/h | 2022-11-04 | 2022-11-08 | 397 | $32.01 | $12.7K | 32,279 | SEC↗ |
| Kenny John P. | Chief Executive Officer | F Tax w/h | 2022-10-03 | 2022-10-05 | 40,269 | $31.53 | $1.27M | 224,862 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | F Tax w/h | 2022-09-16 | 2022-10-05 | 357 | $32.14 | $11.5K | 39,847 | SEC↗ |
| Smith Julie Diana | Sr VP, Controller, PAO | F Tax w/h | 2022-09-16 | 2022-10-05 | 360 | $32.14 | $11.6K | 32,676 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise deriv | 2022-06-27 | 2022-06-28 | 61,437 | — | $0 | 66,039 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2022-06-27 | 2022-06-28 | 61,437 | $30.39 | $1.87M | 265,131 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise | 2022-06-27 | 2022-06-28 | 61,437 | $10.10 | $620.5K | 326,568 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise deriv | 2022-06-24 | 2022-06-28 | 13,559 | — | $0 | 127,476 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2022-06-24 | 2022-06-28 | 13,559 | $30.00 | $406.8K | 265,131 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise | 2022-06-24 | 2022-06-28 | 13,559 | $10.10 | $136.9K | 278,690 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise deriv | 2022-06-23 | 2022-06-24 | 14,607 | — | $0 | 141,035 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise deriv | 2022-06-23 | 2022-06-24 | 5,349 | — | $0 | 0 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise | 2022-06-23 | 2022-06-24 | 5,349 | $14.50 | $77.6K | 270,480 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise | 2022-06-23 | 2022-06-24 | 14,607 | $10.10 | $147.5K | 285,087 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2022-06-23 | 2022-06-24 | 19,956 | $29.98 | $598.3K | 265,131 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise deriv | 2022-06-22 | 2022-06-24 | 44,651 | — | $0 | 5,349 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2022-06-22 | 2022-06-24 | 44,651 | $29.72 | $1.33M | 265,131 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise | 2022-06-22 | 2022-06-24 | 44,651 | $14.50 | $647.4K | 309,782 | SEC↗ |
| Kitzmiller Andrew S. | EVP & CFO | P Buy | 2022-02-25 | 2022-02-28 | 4,028 | $24.87 | $100.2K | 11,528 | SEC↗ |
| Kitzmiller Andrew S. | EVP & CFO | A Award deriv | 2022-02-21 | 2022-02-22 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Kitzmiller Andrew S. | EVP & CFO | A Award | 2022-02-21 | 2022-02-22 | 7,500 | — | $0 | 7,500 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | M Exercise deriv | 2022-02-15 | 2022-02-17 | 7,500 | — | $0 | 2,500 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | M Exercise deriv | 2022-02-15 | 2022-02-17 | 12,500 | — | $0 | 0 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | S Sale | 2022-02-15 | 2022-02-17 | 20,000 | $25.60 | $512.0K | 83,048 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | M Exercise | 2022-02-15 | 2022-02-17 | 7,500 | $14.30 | $107.3K | 103,048 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | M Exercise | 2022-02-15 | 2022-02-17 | 12,500 | $14.65 | $183.1K | 95,548 | SEC↗ |
| Anderson James M. | Director | A Award deriv | 2022-01-26 | 2022-01-28 | 5,656 | — | $0 | 5,656 | SEC↗ |
| Bihl Anthony P III | Director | A Award deriv | 2022-01-26 | 2022-01-28 | 5,656 | — | $0 | 5,656 | SEC↗ |
| Ellingwood Dwight E | Director | A Award deriv | 2022-01-26 | 2022-01-28 | 5,656 | — | $0 | 5,656 | SEC↗ |
| McIlwraith John | Director | A Award deriv | 2022-01-26 | 2022-01-28 | 5,656 | — | $0 | 5,656 | SEC↗ |
| Rice John McCune Jr. | Director | A Award deriv | 2022-01-26 | 2022-01-28 | 5,656 | — | $0 | 5,656 | SEC↗ |
| Sazdanoff Catherine | Director | A Award deriv | 2022-01-26 | 2022-01-28 | 5,656 | — | $0 | 5,656 | SEC↗ |
| Williams Felicia | Director | A Award deriv | 2022-01-26 | 2022-01-28 | 5,656 | — | $0 | 5,656 | SEC↗ |
| Anderson James M. | Director | A Award | 2022-01-26 | 2022-01-28 | 3,012 | — | $0 | 19,724 | SEC↗ |
| Bihl Anthony P III | Director | A Award | 2022-01-26 | 2022-01-28 | 3,012 | — | $0 | 15,408 | SEC↗ |
| Ellingwood Dwight E | Director | A Award | 2022-01-26 | 2022-01-28 | 3,012 | — | $0 | 17,290 | SEC↗ |
| McIlwraith John | Director | A Award | 2022-01-26 | 2022-01-28 | 3,012 | — | $0 | 21,724 | SEC↗ |
| Rice John McCune Jr. | Director | A Award | 2022-01-26 | 2022-01-28 | 3,012 | — | $0 | 27,449 | SEC↗ |
| Sazdanoff Catherine | Director | A Award | 2022-01-26 | 2022-01-28 | 3,012 | — | $0 | 16,424 | SEC↗ |
| Williams Felicia | Director | A Award | 2022-01-26 | 2022-01-28 | 3,012 | — | $0 | 10,274 | SEC↗ |
| PHILLIPS DAVID | Director | M Exercise deriv | 2022-01-12 | 2022-01-14 | 7,500 | — | $0 | 0 | SEC↗ |
| PHILLIPS DAVID | Director | M Exercise | 2022-01-12 | 2022-01-14 | 7,500 | $18.54 | $139.1K | 14,045 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | F Tax w/h | 2021-12-15 | 2021-12-22 | 1,985 | $17.92 | $35.6K | 60,929 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | F Tax w/h | 2021-12-15 | 2021-12-22 | 320 | $17.92 | $5.7K | 83,048 | SEC↗ |
| Kenny John P. | Chief Executive Officer | A Award | 2021-11-15 | 2021-11-16 | 155,511 | — | $0 | 265,131 | SEC↗ |
| Kenny John P. | Chief Executive Officer | J Other | 2021-11-15 | 2021-11-16 | 155,511 | — | $0 | 109,620 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | J Other | 2021-11-15 | 2021-11-16 | 32,557 | — | $0 | 34,164 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | A Award | 2021-11-15 | 2021-11-16 | 32,557 | — | $0 | 66,721 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | J Other | 2021-11-15 | 2021-11-16 | 24,343 | — | $0 | 18,093 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | A Award | 2021-11-15 | 2021-11-16 | 24,343 | — | $0 | 42,436 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | A Award | 2021-11-15 | 2021-11-16 | 32,709 | — | $0 | 87,637 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | J Other | 2021-11-15 | 2021-11-16 | 32,709 | — | $0 | 54,928 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | F Tax w/h | 2021-11-15 | 2021-12-16 | 3,807 | $20.16 | $76.7K | 62,914 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | F Tax w/h | 2021-11-15 | 2021-12-16 | 4,269 | $20.16 | $86.1K | 83,368 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | F Tax w/h | 2021-11-15 | 2021-12-16 | 2,232 | $20.16 | $45.0K | 40,204 | SEC↗ |
| Kenny John P. | Chief Executive Officer | A Award deriv | 2021-11-04 | 2021-11-08 | 82,940 | — | $0 | 82,940 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | A Award deriv | 2021-11-04 | 2021-11-08 | 11,669 | — | $0 | 11,669 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | A Award deriv | 2021-11-04 | 2021-11-08 | 11,669 | — | $0 | 11,669 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | A Award deriv | 2021-11-04 | 2021-11-08 | 11,669 | — | $0 | 11,669 | SEC↗ |
| Kenny John P. | Chief Executive Officer | A Award | 2021-11-04 | 2021-11-08 | 56,472 | — | $0 | 265,131 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | A Award | 2021-11-04 | 2021-11-08 | 10,593 | — | $0 | 66,721 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | A Award | 2021-11-04 | 2021-11-08 | 10,593 | — | $0 | 42,436 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | A Award | 2021-11-04 | 2021-11-08 | 10,593 | — | $0 | 87,637 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2021-03-17 | 2021-03-18 | 30,000 | $25.00 | $750.0K | 208,659 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2021-03-10 | 2021-03-11 | 10,000 | $25.00 | $250.0K | 238,659 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise deriv | 2021-02-16 | 2021-02-17 | 2,082 | — | $0 | 155,642 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2021-02-16 | 2021-02-17 | 2,359 | $30.35 | $71.6K | 248,659 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise | 2021-02-16 | 2021-02-17 | 2,082 | $10.10 | $21.0K | 251,018 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise deriv | 2021-02-12 | 2021-02-16 | 23,097 | — | $0 | 157,724 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2021-02-12 | 2021-02-16 | 26,181 | $30.14 | $789.1K | 248,936 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise | 2021-02-12 | 2021-02-16 | 23,097 | $10.10 | $233.3K | 275,117 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise deriv | 2021-02-11 | 2021-02-16 | 1,164 | — | $0 | 180,821 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise | 2021-02-11 | 2021-02-16 | 1,164 | $10.10 | $11.8K | 253,340 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2021-02-11 | 2021-02-16 | 1,320 | $30.00 | $39.6K | 252,020 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | M Exercise deriv | 2021-02-08 | 2021-02-09 | 3,750 | — | $0 | 0 | SEC↗ |
| Rice John McCune Jr. | Director | M Exercise deriv | 2021-02-08 | 2021-02-09 | 17,205 | — | $0 | 0 | SEC↗ |
| Rice John McCune Jr. | Director | M Exercise deriv | 2021-02-08 | 2021-02-09 | 10,000 | — | $0 | 0 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise deriv | 2021-02-08 | 2021-02-10 | 16,134 | — | $0 | 181,985 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise deriv | 2021-02-08 | 2021-02-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | M Exercise | 2021-02-08 | 2021-02-09 | 3,750 | $19.56 | $73.3K | 62,382 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | S Sale | 2021-02-08 | 2021-02-09 | 6,254 | $30.00 | $187.6K | 56,128 | SEC↗ |
| Rice John McCune Jr. | Director | S Sale | 2021-02-08 | 2021-02-09 | 16,480 | $28.16 | $464.1K | 24,437 | SEC↗ |
| Rice John McCune Jr. | Director | M Exercise | 2021-02-08 | 2021-02-09 | 17,205 | $10.46 | $180.0K | 40,917 | SEC↗ |
| Rice John McCune Jr. | Director | M Exercise | 2021-02-08 | 2021-02-09 | 10,000 | $13.55 | $135.5K | 23,712 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise | 2021-02-08 | 2021-02-10 | 50,000 | $14.50 | $725.0K | 304,330 | SEC↗ |
| Kenny John P. | Chief Executive Officer | M Exercise | 2021-02-08 | 2021-02-10 | 16,134 | $10.10 | $163.0K | 320,464 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2021-02-08 | 2021-02-10 | 68,288 | $29.86 | $2.04M | 252,176 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | M Exercise deriv | 2021-02-05 | 2021-02-08 | 11,250 | — | $0 | 3,750 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2021-02-05 | 2021-02-08 | 20,000 | $25.00 | $500.0K | 254,330 | SEC↗ |
| Kenny John P. | Chief Executive Officer | S Sale | 2021-02-05 | 2021-02-08 | 20,000 | $25.00 | $500.0K | 274,330 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | S Sale | 2021-02-05 | 2021-02-08 | 14,250 | $26.61 | $379.2K | 58,632 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | M Exercise | 2021-02-05 | 2021-02-08 | 11,250 | $19.56 | $220.1K | 72,882 | SEC↗ |
| Anderson James M. | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 5,796 | — | $0 | 5,796 | SEC↗ |
| Bihl Anthony P III | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 5,796 | — | $0 | 5,796 | SEC↗ |
| Ellingwood Dwight E | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 5,796 | — | $0 | 5,796 | SEC↗ |
| McIlwraith John | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 5,796 | — | $0 | 5,796 | SEC↗ |
| PHILLIPS DAVID | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 5,796 | — | $0 | 5,796 | SEC↗ |
| Rice John McCune Jr. | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 5,796 | — | $0 | 5,796 | SEC↗ |
| Sazdanoff Catherine | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 5,796 | — | $0 | 5,796 | SEC↗ |
| Williams Felicia | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 5,796 | — | $0 | 5,796 | SEC↗ |
| Anderson James M. | Director | A Award | 2021-01-27 | 2021-01-29 | 1,545 | — | $0 | 16,712 | SEC↗ |
| Bihl Anthony P III | Director | A Award | 2021-01-27 | 2021-01-29 | 1,545 | — | $0 | 12,396 | SEC↗ |
| Ellingwood Dwight E | Director | A Award | 2021-01-27 | 2021-01-29 | 1,545 | — | $0 | 14,278 | SEC↗ |
| McIlwraith John | Director | A Award | 2021-01-27 | 2021-01-29 | 1,545 | — | $0 | 18,712 | SEC↗ |
| PHILLIPS DAVID | Director | A Award | 2021-01-27 | 2021-01-29 | 1,545 | — | $0 | 7,342 | SEC↗ |
| Rice John McCune Jr. | Director | A Award | 2021-01-27 | 2021-01-29 | 1,545 | — | $0 | 13,712 | SEC↗ |
| Sazdanoff Catherine | Director | A Award | 2021-01-27 | 2021-01-29 | 1,545 | — | $0 | 13,412 | SEC↗ |
| Williams Felicia | Director | A Award | 2021-01-27 | 2021-01-29 | 1,545 | — | $0 | 7,262 | SEC↗ |
| Bihl Anthony P III | Director | P Buy | 2020-11-25 | 2020-11-30 | 5,000 | $17.65 | $88.3K | 10,851 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | F Tax w/h | 2020-11-23 | 2020-12-21 | 157 | $19.08 | $3.0K | 77,044 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2020-11-17 | 2020-11-18 | 796 | — | $0 | 51,496 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2020-11-17 | 2020-11-18 | 796 | — | $0 | 5,797 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | F Tax w/h | 2020-11-16 | 2020-12-21 | 1,991 | $17.11 | $34.1K | 61,632 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | F Tax w/h | 2020-11-16 | 2020-12-21 | 2,509 | $17.11 | $42.9K | 77,201 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | A Award deriv | 2020-11-05 | 2020-11-09 | 12,107 | — | $0 | 12,107 | SEC↗ |
| Kenny John P. | Chief Executive Officer | A Award deriv | 2020-11-05 | 2020-11-09 | 83,535 | — | $0 | 83,535 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | A Award deriv | 2020-11-05 | 2020-11-09 | 12,107 | — | $0 | 12,107 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | A Award deriv | 2020-11-05 | 2020-11-09 | 12,107 | — | $0 | 12,107 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | A Award | 2020-11-05 | 2020-11-09 | 10,823 | — | $0 | 63,623 | SEC↗ |
| Kenny John P. | Chief Executive Officer | A Award | 2020-11-05 | 2020-11-09 | 56,006 | — | $0 | 294,330 | SEC↗ |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | A Award | 2020-11-05 | 2020-11-09 | 10,823 | — | $0 | 31,843 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | A Award | 2020-11-05 | 2020-11-09 | 12,175 | — | $0 | 79,710 | SEC↗ |
| Bihl Anthony P III | Director | P Buy | 2020-08-11 | 2020-08-12 | 5,000 | $17.99 | $89.9K | 5,851 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2020-08-10 | 2020-08-11 | 797 | — | $0 | 6,593 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2020-08-10 | 2020-08-11 | 797 | — | $0 | 50,700 | SEC↗ |
| Bihl Anthony P III | Director | A Award deriv | 2020-07-28 | 2020-07-29 | 4,595 | — | $0 | 4,595 | SEC↗ |
| Bihl Anthony P III | Director | A Award deriv | 2020-07-28 | 2020-08-12 | 4,595 | — | $0 | 4,595 | SEC↗ |
| Bihl Anthony P III | Director | A Award | 2020-07-28 | 2020-07-29 | 851 | — | $0 | 851 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | M Exercise deriv | 2020-06-30 | 2020-07-02 | 1,500 | — | $0 | 0 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | F Tax w/h | 2020-06-30 | 2020-07-02 | 1,337 | $23.29 | $31.1K | 52,800 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | M Exercise | 2020-06-30 | 2020-07-02 | 1,500 | $19.71 | $29.6K | 54,137 | SEC↗ |
| Williams Felicia | Director | P Buy | 2020-03-16 | 2020-03-17 | 1,550 | $6.02 | $9.3K | 5,717 | SEC↗ |
| Kenny John P. | Chief Executive Officer | P Buy | 2020-03-12 | 2020-03-13 | 30,000 | $5.78 | $173.4K | 238,324 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | P Buy | 2020-03-10 | 2020-03-11 | 1,000 | $6.96 | $7.0K | 52,637 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | P Buy | 2020-03-10 | 2020-03-11 | 1,000 | $6.98 | $7.0K | 51,637 | SEC↗ |
| McIlwraith John | Director | P Buy | 2020-02-25 | 2020-02-26 | 5,000 | $7.59 | $38.0K | 17,167 | SEC↗ |
| Rice John McCune Jr. | Director | P Buy | 2020-02-24 | 2020-02-26 | 3,000 | $7.52 | $22.6K | 12,167 | SEC↗ |
| Kenny John P. | Chief Executive Officer | P Buy | 2020-02-21 | 2020-02-24 | 10,000 | $7.65 | $76.5K | 208,324 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2020-02-11 | 2020-02-12 | 246 | — | $0 | 49,107 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2020-02-11 | 2020-02-12 | 246 | — | $0 | 8,186 | SEC↗ |
| Anderson James M. | Director | A Award deriv | 2020-01-29 | 2020-01-31 | 17,205 | — | $0 | 17,205 | SEC↗ |
| Ellingwood Dwight E | Director | A Award deriv | 2020-01-29 | 2020-01-31 | 17,205 | — | $0 | 17,205 | SEC↗ |
| McIlwraith John | Director | A Award deriv | 2020-01-29 | 2020-01-31 | 17,205 | — | $0 | 17,205 | SEC↗ |
| PHILLIPS DAVID | Director | A Award deriv | 2020-01-29 | 2020-01-31 | 17,205 | — | $0 | 17,205 | SEC↗ |
| Rice John McCune Jr. | Director | A Award deriv | 2020-01-29 | 2020-01-31 | 17,205 | — | $0 | 17,205 | SEC↗ |
| Sazdanoff Catherine | Director | A Award deriv | 2020-01-29 | 2020-01-31 | 17,205 | — | $0 | 17,205 | SEC↗ |
| Williams Felicia | Director | A Award deriv | 2020-01-29 | 2020-01-31 | 17,205 | — | $0 | 17,205 | SEC↗ |
| Anderson James M. | Director | A Award | 2020-01-29 | 2020-01-31 | 3,186 | — | $0 | 15,167 | SEC↗ |
| Ellingwood Dwight E | Director | A Award | 2020-01-29 | 2020-01-31 | 3,186 | — | $0 | 12,733 | SEC↗ |
| McIlwraith John | Director | A Award | 2020-01-29 | 2020-01-31 | 3,186 | — | $0 | 12,167 | SEC↗ |
| PHILLIPS DAVID | Director | A Award | 2020-01-29 | 2020-01-31 | 3,186 | — | $0 | 8,432 | SEC↗ |
| Rice John McCune Jr. | Director | A Award | 2020-01-29 | 2020-01-31 | 3,186 | — | $0 | 9,167 | SEC↗ |
| Sazdanoff Catherine | Director | A Award | 2020-01-29 | 2020-01-31 | 3,186 | — | $0 | 11,867 | SEC↗ |
| Williams Felicia | Director | A Award | 2020-01-29 | 2020-01-31 | 3,186 | — | $0 | 4,167 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | F Tax w/h | 2019-11-22 | 2019-11-25 | 158 | $8.80 | $1.4K | 67,535 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2019-11-19 | 2019-11-20 | 245 | — | $0 | 5,246 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2019-11-19 | 2019-11-20 | 245 | — | $0 | 48,861 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | F Tax w/h | 2019-11-18 | 2019-11-19 | 1,968 | $8.56 | $16.8K | 50,637 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | F Tax w/h | 2019-11-18 | 2019-11-19 | 1,260 | $8.56 | $10.8K | 67,693 | SEC↗ |
| PHILLIPS DAVID | Director | P Buy | 2019-11-12 | 2019-11-13 | 10,000 | $8.06 | $80.6K | 48,616 | SEC↗ |
| Kenny John P. | Chief Executive Officer | P Buy | 2019-11-08 | 2019-11-12 | 20,000 | $7.73 | $154.6K | 198,324 | SEC↗ |
| Kenny John P. | Chief Executive Officer | A Award deriv | 2019-11-05 | 2019-11-07 | 198,119 | — | $0 | 198,119 | SEC↗ |
| Kenny John P. | Chief Executive Officer | A Award | 2019-11-05 | 2019-11-07 | 99,505 | — | $0 | 178,324 | SEC↗ |
| Baldasare Bryan T | Exec VP & CFO | A Award | 2019-10-31 | 2019-11-04 | 20,534 | — | $0 | 52,605 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | A Award | 2019-10-31 | 2019-11-04 | 20,534 | — | $0 | 68,953 | SEC↗ |
| Kenny John P. | Chief Executive Officer | F Tax w/h | 2019-10-11 | 2019-10-15 | 4,181 | $8.83 | $36.9K | 78,819 | SEC↗ |
| Baldasare Bryan T | Interim CFO & Chief Acctg Of | A Award | 2019-09-16 | 2019-09-23 | 1,200 | — | $0 | 32,071 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2019-08-16 | 2019-08-19 | 245 | — | $0 | 38,616 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2019-08-16 | 2019-08-19 | 245 | — | $0 | 5,491 | SEC↗ |
| Rice John McCune Jr. | Director | J Other | 2019-05-22 | 2019-05-23 | 981 | — | $0 | 3,981 | SEC↗ |
| Rice John McCune Jr. | Director | J Other | 2019-05-22 | 2019-05-23 | 981 | — | $0 | 0 | SEC↗ |
| Rice John McCune Jr. | Director | P Buy | 2019-05-22 | 2019-05-23 | 2,000 | $11.26 | $22.5K | 5,981 | SEC↗ |
| Anderson James M. | Director | P Buy | 2019-05-16 | 2019-05-20 | 5,000 | $11.37 | $56.8K | 11,981 | SEC↗ |
| Anderson James M. | Director | J Other | 2019-05-16 | 2019-05-20 | 981 | — | $0 | 0 | SEC↗ |
| Anderson James M. | Director | J Other | 2019-05-16 | 2019-05-20 | 981 | — | $0 | 6,981 | SEC↗ |
| PHILLIPS DAVID | Director | P Buy | 2019-05-13 | 2019-05-13 | 5,000 | $11.40 | $57.0K | 38,371 | SEC↗ |
| PHILLIPS DAVID | Director | J Other | 2019-05-10 | 2019-05-13 | 981 | — | $0 | 5,981 | SEC↗ |
| PHILLIPS DAVID | Director | J Other | 2019-05-10 | 2019-05-13 | 981 | — | $0 | 0 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2019-05-10 | 2019-05-13 | 245 | — | $0 | 33,371 | SEC↗ |
| PHILLIPS DAVID | Director | G Gift | 2019-05-10 | 2019-05-13 | 245 | — | $0 | 5,736 | SEC↗ |
| Kenny John P. | Chief Executive Officer | P Buy | 2019-05-08 | 2019-05-09 | 20,000 | $11.49 | $229.8K | 83,000 | SEC↗ |
| Ellingwood Dwight E | Director | J Other | 2019-02-21 | 2019-02-25 | 981 | — | $0 | 0 | SEC↗ |
| Ellingwood Dwight E | Director | J Other | 2019-02-21 | 2019-02-25 | 981 | — | $0 | 9,547 | SEC↗ |
| Anderson James M. | Director | A Award deriv | 2019-01-24 | 2019-01-28 | 8,740 | — | $0 | 8,740 | SEC↗ |
| Ellingwood Dwight E | Director | A Award deriv | 2019-01-24 | 2019-01-28 | 8,740 | — | $0 | 8,740 | SEC↗ |
| McIlwraith John | Director | A Award deriv | 2019-01-24 | 2019-01-28 | 8,740 | — | $0 | 8,740 | SEC↗ |
| PHILLIPS DAVID | Director | A Award deriv | 2019-01-24 | 2019-01-28 | 8,740 | — | $0 | 8,740 | SEC↗ |
| Rice John McCune Jr. | Director | A Award deriv | 2019-01-24 | 2019-01-28 | 8,740 | — | $0 | 8,740 | SEC↗ |
| Sazdanoff Catherine | Director | A Award deriv | 2019-01-24 | 2019-01-28 | 8,740 | — | $0 | 8,740 | SEC↗ |
| Williams Felicia | Director | A Award deriv | 2019-01-24 | 2019-01-28 | 8,740 | — | $0 | 8,740 | SEC↗ |
| Anderson James M. | Director | A Award | 2019-01-24 | 2019-01-28 | 981 | — | $0 | 981 | SEC↗ |
| Ellingwood Dwight E | Director | A Award | 2019-01-24 | 2019-01-28 | 981 | — | $0 | 981 | SEC↗ |
| McIlwraith John | Director | A Award | 2019-01-24 | 2019-01-28 | 981 | — | $0 | 981 | SEC↗ |
| PHILLIPS DAVID | Director | A Award | 2019-01-24 | 2019-01-28 | 981 | — | $0 | 981 | SEC↗ |
| Rice John McCune Jr. | Director | A Award | 2019-01-24 | 2019-01-28 | 981 | — | $0 | 981 | SEC↗ |
| Sazdanoff Catherine | Director | A Award | 2019-01-24 | 2019-01-28 | 981 | — | $0 | 981 | SEC↗ |
| Williams Felicia | Director | A Award | 2019-01-24 | 2019-01-28 | 981 | — | $0 | 981 | SEC↗ |
| BALDINI LAWRENCE | EVP, Global Operations | F Tax w/h | 2018-12-15 | 2019-02-25 | 407 | $17.47 | $7.1K | 75,528 | SEC↗ |
| LUEKE MELISSA | Exec VP, CFO | F Tax w/h | 2018-12-15 | 2019-02-25 | 1,304 | $17.47 | $22.8K | 169,776 | SEC↗ |
| Ellingwood Dwight E | Director | P Buy | 2018-11-28 | 2019-02-25 | 31 | $18.42 | $571 | 8,566 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | F Tax w/h | 2018-11-21 | 2019-02-25 | 158 | $18.14 | $2.9K | 48,419 | SEC↗ |
| Rice John McCune Jr. | Director | M Exercise deriv | 2018-11-20 | 2018-11-21 | 2,000 | — | $0 | 10,000 | SEC↗ |
| Rice John McCune Jr. | Director | M Exercise | 2018-11-20 | 2018-11-21 | 2,000 | $13.55 | $27.1K | 3,000 | SEC↗ |
| BALDINI LAWRENCE | EVP, Global Operations | F Tax w/h | 2018-11-16 | 2018-11-19 | 2,818 | $19.15 | $54.0K | 75,935 | SEC↗ |
| LUEKE MELISSA | Exec VP, CFO | F Tax w/h | 2018-11-16 | 2018-11-19 | 2,818 | $19.15 | $54.0K | 171,080 | SEC↗ |
| ROLIH SUSAN | EVP, Global Reg & Quality Sy | F Tax w/h | 2018-11-16 | 2018-11-19 | 2,809 | $19.15 | $53.8K | 168,280 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | F Tax w/h | 2018-11-16 | 2018-11-19 | 608 | $19.15 | $11.6K | 48,577 | SEC↗ |
| Kenny John P. | Chief Executive Officer | A Award | 2018-11-15 | 2018-11-19 | 25,000 | — | $0 | 63,000 | SEC↗ |
| Rasmussen Eric S. | EVP, Bus. Development/Strate | A Award | 2018-11-15 | 2018-11-19 | 17,500 | — | $0 | 22,500 | SEC↗ |
| BALDINI LAWRENCE | EVP, Global Operations | A Award | 2018-11-15 | 2018-11-19 | 12,500 | — | $0 | 78,753 | SEC↗ |
| LUEKE MELISSA | Exec VP, CFO | A Award | 2018-11-15 | 2018-11-19 | 12,500 | — | $0 | 173,898 | SEC↗ |
| ROLIH SUSAN | EVP, Global Reg & Quality Sy | A Award | 2018-11-15 | 2018-11-19 | 12,500 | — | $0 | 171,089 | SEC↗ |
| WELTZIEN LOURDES | EVP, Life Science | A Award | 2018-11-15 | 2018-11-19 | 12,500 | — | $0 | 49,185 | SEC↗ |